CSIMarket
 
Sigmatron International Inc  (SGMA)
Other Ticker:  
 
    Sector  Technology    Industry Semiconductors
   Industry Semiconductors
   Sector  Technology
 



EARNINGS REPORT by CSIMarket

EPS Unchanged, Revenues Down

Sigmatron International Inc announced fiscal second quarter 2020 operating profit of $1.337803 millions

Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonFor the fiscal second quarter 2020 Sigmatron International Inc eps remained unchanged of $0.15 per share compare to $0.15 a year ago and EPS turn positive from $-0.21 per share from the previous quarter.

Sales declined by -7 % to $70 millions from $75 millions in the same quarter a year ago and sequentially Sales improved by 15.02 % from $61 millions.



Net income of $0.627 millions in the fiscal second quarter 2020 fell by -5.19 % from break-even in the corresponding period a year before. Sigmatron International Inc also emphasized it's improving profit margins, where net margin rose to 0.9% in fiscal second quarter 2020, and operating margin edged up to 1.92%.


Sigmatron International Inc is expected to report next financial results on March 15, 2021.


    Recently Reported Results
switch_inside_pd Infinera Corp

Redemption of Losses due Decrease in Demand

Lower demand led to lower revenues and higher loss, in the fourth quarter of 2020 company decreased loss to $-0.05 per share, while Sales fell by -8.07% to $353.53 millions, year on year.

In the previous quarter company realized Sales of $340.21 millions and bottom line of $-0.19 per share.
Infinera Corp reported net loss of $-206.72 millions and Sales of $1.36 billions for the fiscal year 2020.

Company has decreased loss per share to $-1.10 from $-2.16 in the previous fiscal year, while Sales increased by 4.37 % from $1.30 billions a year ago.

INFN stock quotes, charts, profile

Growth Rates, Profitability, PE

factory-2937337_960_720 Durable Goods Orders

New orders accelerate in December

New orders increased on the faster pace again, excluding defense booking grew even faster 1.05 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.

3729671365_1597e74cfc_z Bluelinx Holdings Inc

Bluelinx Holdings Inc announced fourth quarter of 2020 operating surplus of $32.407 millions

Due to strong revenue growth company turned into profitability, Sales grew by 25.07% to $848.82 millions, earnings per share were at $2.77, compared to $-0.75 in the same quarter a year ago.

Sequentially profit plummeted by -51.6% from $5.72 per share and Sales decreased by -2.55% from $871.06 millions.
Bluelinx Holdings Inc reported earnings of $80.88 millions and Sales of $3.10 billions for the fiscal year 2020.

Company reported earnings per share of $8.55 compared to $-1.89 in the previous fiscal year, while Sales improved by 17.44 % from $2.64 billions a year ago.

BXC stock quotes, charts, profile

Growth Rates, Profitability, PE

gas_station_By_Xnatedawgx_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Calumet Specialty Products Partners L p

Deficit Bigger Than a Year Ago, Sales Faded

Weak demand caused increase in losses for the financial fourth quarter of 2020, company's deficit per share grew to $-0.51 from $-0.48 where Sales fell by -28.51% to $553.90 millions from $774.80 millions a year ago.

In contrast to the third quarter Sales decreased by -2.48% from $568.00 millions and improved from $-0.70 per share.
Calumet Specialty Products Partners L P reported net loss of $-149.00 millions and Sales of $2.27 billions for the fiscal year 2020.

Net loss per share has widen to $-1.86 from $-0.55 in previous fiscal year, while Sales Tumbled by -34.3 % from $3.45 billions a year ago.

CLMT stock quotes, charts, profile

Growth Rates, Profitability, PE

8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Kallo Inc

Losses Widen but Revenues Unchanged

In the fourth quarter of 2020 Kallo Inc increased losses of $-0.03 per share compared to $-0.00 a year ago and increased losses from $-0.01 per share from the previous quarter.

Kallo Inc reported operating shortfall of $-35.557435 millions, in the fourth quarter of 2020, a deterioration from the operating shortfall of $-1.728984 millions, realized in fourth quarter of 2019
Kallo Inc reported net loss of $-36.06 millions and Sales of $0.00 millions for the fiscal year 2020.

Net loss per share has widen to $-0.03 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.

KALO stock quotes, charts, profile

Growth Rates, Profitability, PE

Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

New Orders up 1.29 % in December

Factory orders continued to grow, excluding defense, booking grew even faster 1.56 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.

dollar-1175048_960_720 Gross Domestic Product

GDP grew by 4.1 % in the fourth-quarter

The Gross domestic product, the measurement of the nations output, improved in the fourth-quarter, as private domestic investments and foreign demand for American products pick up.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The growth of industrial output picks up in December

The industrial production growth rate accelerated compare to the slow down in previous month, due to increase in growing output at utilities.

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Ampio Pharmaceuticals inc

Ampio Pharmaceuticals Inc announced fiscal time frame ending Dec 31 2020 operating loss of $-3.911 millions

In the fiscal time frame ending Dec 31 2020 Ampio Pharmaceuticals Inc loss increased of $-0.02 per share compared to $-0.01 a year ago and from $-0.02 per share from the previous quarter.

Ampio Pharmaceuticals Inc reported operating shortfall of $-3.911 millions, in the fiscal time frame ending Dec 31 2020, an improvement from the operating shortfall of $-7.145966 millions, realized in fourth quarter of 2019
Ampio Pharmaceuticals Inc reported net loss of $-15.89 millions and Sales of $0.00 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.09 from $-0.14 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

AMPE stock quotes, charts, profile

Growth Rates, Profitability, PE

BuySell_pd.jpg Cowen inc

Cowen Inc announced fourth quarter of 2020 earnings season operating income of $153.148 millions

Cowen Inc delivered very strong results in the fourth quarter of 2020 earnings season, where Sales soared by 78.89% to $502.92 millions, while company's earnings per share soared by 2512.48 % to $3.00 per share, from the same quarter a year ago.

In contrast to the third quarter Sales improved by 29.71 % from $387.74 millions and eps more than doubled by 383.3 % from $0.62 per share.
In the fiscal year 2020, Cowen Inc reported Sales of $1.62 billions and net income of $207.06 millions.

Eps surged by 1145.61 % to $7.10 per share from $0.57 in the previous fiscal year, while Sales surged by 54.68 % from $1.05 billions a year ago.

COWN stock quotes, charts, profile

Growth Rates, Profitability, PE

wines_in_a_supermarket_By_francois_from_Strasbourg,_france_(Small_french_supermarket)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Brown forman Corporation

Brown Forman Corporation announced third quarter of 2020 earnings season operating surplus of $281 millions

Brown Forman Corporation reported declining eps on increasing revenue in the third quarter of 2020 earnings season, where Sales grew by 3.74% to $1.22 billions in comparison to $1.18 billions on a year-over-year basis, while earnings decreased by -6.25% to $0.45 per share, income per share was $0.48 in the same quarter a year ago.

In the previous quarter company realized Sales of $1.27 billions and bottom line of $0.50 per share.

BFA stock quotes, charts, profile

Growth Rates, Profitability, PE

Halffullorhalfempty Annovis Bio Inc

Annovis Bio Inc announced financial fourth quarter of 2020 operating shortfall of $-1.909673 millions

For the financial fourth quarter of 2020 Annovis Bio Inc lost money at $-0.25 per share, compared to results of $-0.87 per share a year ago quarter, In the previous quarter company realized $-0.15 per share.

from $0.00 millions in preceding quarter, increased losses from $-0.15 per share.
Annovis Bio Inc reported net loss of $-5.46 millions and Sales of $-0.03 millions for the fiscal year 2020.

Company recorded loss per share of $-0.87 compared to $1.73 in the previous fiscal year, while by -100 % from $4.28 billions a year ago.

ANVS stock quotes, charts, profile

Growth Rates, Profitability, PE

Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Soleno Therapeutics Inc

Soleno Therapeutics Inc announced most recent fiscal period operating loss of $-7.957 millions

In the most recent fiscal period Soleno Therapeutics Inc decreased loss of $-0.04 per share compared to $-0.35 a year ago and improved from $-0.11 per share from the previous quarter.

Soleno Therapeutics Inc reported operating loss of $-7.957 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-6.752 millions, realized in fourth quarter of 2019
Soleno Therapeutics Inc reported net loss of $-24.64 millions and Sales of $0.00 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.39 from $-0.90 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

SLNO stock quotes, charts, profile

Growth Rates, Profitability, PE

Medical_ultrasound_examination_pd Optinose Inc

Optinose Inc announced fiscal period ending Dec 31 2020 operating loss of $-20.45 millions

Company lost money at $-0.46 per share in the fiscal period ending Dec 31 2020, although its Sales surged by 47.52% to $16.35 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $15.44 millions and $-0.43 per share.
Optinose Inc reported net loss of $-99.79 millions and Sales of $49.12 millions for the fiscal year 2020.

Company has decreased loss per share to $-2.07 from $-2.63 in the previous fiscal year, while Sales surged by 41.83 % from $34.63 millions a year ago.

OPTN stock quotes, charts, profile

Growth Rates, Profitability, PE



Other SGMA's Earnings Reports

Sigmatron International Inc reported first quarter 2020 earnings

Sigmatron International Inc reported fourth quarter 2020 earnings

Sigmatron International Inc reported third quarter 2019 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PHG's Profile

Stock Price

PHG's Financials

Business Description

Fundamentals

Charts & Quotes

PHG's News

Suppliers

PHG's Competitors

Customers & Markets

Economic Indicators

PHG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071